A Phase I/II Study of Adjuvant Prostate Irradiation and Ixabepilone For High Risk Prostate Cancer Post-Prostatectomy.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ixabepilone (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 11 Jun 2010 Actual initiation date (May 2012) added as reported by ClinicalTrials.gov.
- 08 Mar 2010 New trial record